Human Metabolome Technologies, Inc. Stock
Equities
6090
JP3794530000
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
655 JPY | -1.06% | -2.38% | +2.34% |
Sales 2022 | 1.22B 7.72M | Sales 2023 | 1.3B 8.2M | Capitalization | 4.42B 27.93M |
---|---|---|---|---|---|
Net income 2022 | 267M 1.69M | Net income 2023 | 285M 1.8M | EV / Sales 2022 | 2.48 x |
Net cash position 2022 | 1.27B 8.03M | Net cash position 2023 | 1.43B 9.03M | EV / Sales 2023 | 2.31 x |
P/E ratio 2022 |
16.1
x | P/E ratio 2023 |
15.5
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
1.34% | Free-Float | 80.56% |
1 day | -1.06% | ||
1 week | -2.38% | ||
1 month | +1.87% | ||
3 months | -0.91% | ||
6 months | -4.93% | ||
Current year | +2.34% |
Managers | Title | Age | Since |
---|---|---|---|
President | 55 | 18-02-28 | |
Tomomi Ishihara
ADM | Chief Administrative Officer | - | - |
Takaomi Fukuhara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yasuhiro Ohata
BRD | Director/Board Member | 59 | 20-06-30 |
Corporate Officer/Principal | 49 | 05-06-30 | |
Toshio Nagae
BRD | Director/Board Member | 80 | 17-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 655 | -1.06% | 8,000 |
24-04-25 | 662 | +0.46% | 1,900 |
24-04-24 | 659 | -0.45% | 4,100 |
24-04-23 | 662 | +0.15% | 900 |
24-04-22 | 661 | -1.49% | 2,600 |
Delayed Quote Japan Exchange, April 26, 2024 at 01:37 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+2.34% | 24.61M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 6090 Stock